Hormonal therapy for HER2 positive breast cancer
Breast cancer is one of the most common cancers affecting women worldwide. In the United States, it is estimated that one in eight women will be diagnosed with breast cancer in their lifetime. Though it can affect anyone, breast cancer is predominantly found in women over the age of 50.
HER2 (human epidermal growth factor receptor 2) is a protein that is overexpressed in some breast cancer patients. It is found in 20-30% of all breast cancer patients. HER2 positive breast cancer tends to be more aggressive than other types of breast cancer, but there are treatments available, including hormonal therapy.
Hormonal therapy is a type of treatment that uses hormones or drugs that block the effects of hormones to stop or slow the growth of cancer cells. It is used alongside other treatments, such as surgery, radiation therapy, and chemotherapy.
There are different types of hormonal therapy available for HER2 positive breast cancer. One of the most commonly used is the drug tamoxifen. Tamoxifen is a selective estrogen receptor modulator (SERM) that blocks the effects of estrogen on breast tissue. It is used to treat both early and advanced breast cancer.
Another hormonal therapy drug used for HER2 positive breast cancer is aromatase inhibitors. Aromatase inhibitors work by blocking the enzyme aromatase, which is responsible for producing estrogen in postmenopausal women. This helps to reduce the levels of estrogen in the body, which can help to slow or stop the growth of cancer cells.
In addition to these drugs, there are also other types of hormonal therapy available, including ovarian suppression and GnRH agonists. Ovarian suppression works by stopping the ovaries from producing estrogen, while GnRH agonists work by blocking the production of estrogen in the body.
Hormonal therapy is an effective treatment option for HER2 positive breast cancer. It can help to shrink tumors, prevent the cancer from spreading, and reduce the risk of recurrence. It is often used in combination with other treatments, such as surgery and radiation therapy.
However, like all treatments, hormonal therapy does have some side effects. The most common side effects include hot flashes, mood swings, and vaginal dryness. In rare cases, hormonal therapy can also increase the risk of blood clots and endometrial cancer.
It is important for women with HER2 positive breast cancer to work closely with their healthcare team to determine the best course of treatment for their individual needs. Hormonal therapy is just one of many treatment options available, and it may not be suitable or effective for everyone.
In conclusion, hormonal therapy is a valuable treatment option for HER2 positive breast cancer. It works by targeting the hormones that fuel the growth of cancer cells, helping to slow or stop their growth. Though it does have some side effects, it is generally well-tolerated and can be used alongside other treatments, such as surgery and radiation therapy. If you have been diagnosed with HER2 positive breast cancer, speak with your healthcare provider to determine the best treatment plan for your individual needs. Remember, early detection and treatment can greatly improve outcomes for breast cancer patients.